Friday, March 15, 2024 1:03:37 PM
447 Broadway, 2nd Floor
Unit 103
New York, NY 10013
March 15, 2024 - Supplemental Information Disclosure for VG Life Sciences, Inc. (the
“Company”):
On March 13, 2024, the Company retained Fruci & Associates II, PLLC as its new independent
audit firm to complete the 2022 and 2023 full year audits of the Company’s financial records.
The Company will continue to keep shareholders informed of developments.
The Company’s new official Twitter [X] account is @VGLSIR
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM